Averin Capital — VC Firm

Averin Capital is an early-stage venture capital firm based in New York, United States. The firm invests in AI and breakthrough technologies transforming human health.

Founded in 2024 by David and Eric Berry, Averin Capital combines technology judgment, scientific and medical expertise, and firsthand company-building experience. The firm maintains a focus on the AI/ML, healthcare, and robotics sectors.

Averin Capital is an early-stage venture capital firm headquartered in New York, United States, with a focus on investing in artificial intelligence and breakthrough technologies that are transforming human health. Founded in 2024 by David and Eric Berry, the firm leverages its deep domain expertise and firsthand company-building experience to support ambitious founders. Averin Capital's investment strategy centers on sectors such as AI/ML, healthcare, and robotics, with a particular emphasis on technologies that reshape human health.

The firm has a portfolio of six companies, predominantly in the healthcare sector, including Mendaera, Hologen AI, Pine Park Health, Biolinq, CandidPro, and Freenome. Averin Capital's team, comprising founders, operators, physicians, scientists, healthcare executives, and finance leaders, collaborates to evaluate technical, scientific, commercial, and company-building questions. With $500 million in assets under management, Averin Capital aims to empower exceptional teams to unlock their fullest potential and navigate challenges with confidence.

Averin Capital is a vc firm based in New York, United States. The firm focuses on AI / ML, Healthcare.

Averin Capital manages approximately $500M in assets. Our records include 2 funds raised by the firm.

Investing since at least 2023, Averin Capital has backed 6 companies in our records, including Mendaera, Pine Park Health, Hologen AI. Its most recent recorded investment was in 2026, with 1 investment logged in 2026.

Averin Capital has recorded six investments. The earliest recorded investment year is 2023 and the most recent is 2026. The firm has assets under management of 500 million dollars.

Its recorded portfolio includes Mendaera, Hologen AI, Pine Park Health, Biolinq, CandidPro, and Freenome. All portfolio companies except Freenome, which is public, were early-stage healthcare investments at the time of investment.